CNST
Income statement / Annual
Last year (2020), Constellation Pharmaceuticals, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2020, Constellation Pharmaceuticals, Inc.'s net income was -$126.36 M.
See Constellation Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$95.50 M
|
$66.46 M
|
$48.77 M
|
$32.62 M
|
$27.88 M
|
| General & Administrative Expenses |
$29.35 M
|
$19.60 M
|
$12.48 M
|
$6.47 M
|
$5.78 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$29.35 M
|
$19.60 M
|
$12.48 M
|
$6.47 M
|
$5.78 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$124.85 M
|
$86.06 M
|
$61.24 M
|
$39.09 M
|
$33.66 M
|
| Cost And Expenses |
$124.85 M
|
$86.06 M
|
$61.24 M
|
$39.09 M
|
$33.66 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$2.86 M
|
$2.12 M
|
$228.00 K
|
$901.00 K
|
$1.35 M
|
| Depreciation & Amortization |
$644.00 K
|
$758.00 K
|
$562.00 K
|
$474.00 K
|
$203.00 K
|
| EBITDA |
-$122.81 M |
-$82.65 M |
-$59.14 M |
-$34.00 M |
-$32.99 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$1.47 M
|
$529.00 K
|
$1.32 M
|
$3.71 M
|
-$875.00 K
|
| Income Before Tax |
-$126.32 M
|
-$85.53 M
|
-$59.93 M
|
-$35.38 M
|
-$34.53 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$39.00 K
|
$24.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$126.36 M
|
-$85.55 M
|
-$59.93 M
|
-$35.38 M
|
-$34.53 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-2.65 |
-3.04 |
-5 |
-3.03 |
-28.8 |
| EPS Diluted |
-2.65 |
-3.04 |
-5 |
-3.03 |
-28.8 |
| Weighted Average Shares Out |
$47.69 M
|
$28.15 M
|
$11.98 M
|
$11.69 M
|
$1.20 M
|
| Weighted Average Shares Out Diluted |
$47.69 M
|
$28.15 M
|
$11.98 M
|
$11.69 M
|
$1.20 M
|
| Link |
|
|
|
|
|
